Why it can take time and effort to find the right meds to help mental health

The Long, Uncertain Road to Finding the Right Mental Health Medication

Activelifezero.com – For millions of Americans living with depression, anxiety, or other psychiatric conditions, the search for a medication that actually works can feel like navigating a maze with shifting walls. Weeks pass before a prescribed drug begins to take effect. Side effects emerge, fade, or persist. A physician may need to adjust dosages, swap one compound for another, or combine treatments altogether. The process is slow, individualized, and far from guaranteed. And when it goes wrong — or when a patient’s condition is misread — the consequences can be devastating.

The Lindsay Clancy trial, which concluded its deliberations in late August 2026, laid bare just how fragile that process can be. Clancy, a 36-year-old labor-and-delivery nurse, killed her three children in 2023 by strangling them, then slashed her own wrists and throat before leaping from a second-story window. In the days leading up to the act, she had been cycling through dozens of prescriptions meant to manage depression, anxiety, and related conditions. Mental health clinicians who treated her told the court she repeatedly requested changes to her regimen. The night before the killings, she typed a message into her phone:

“Medication stole my motherhood and my life.”

Prosecutors displayed that note briefly to the jury. In closing arguments, prosecutor Jennifer Sprague argued the sequence of events demonstrated premeditation. She contended that Clancy understood the difference between right and wrong, had misled her treating providers, and failed to follow medication instructions as directed.

“She knows, as a nurse, the importance of following the instructions of your medications,” Sprague told the jury.

Clancy’s defense attorney, Kevin Riddington, painted a different picture. He argued his client was overmedicated and experiencing a psychotic episode that removed her criminal responsibility. He pointed to a rare diagnosis called postpartum psychosis, a condition that, research indicates, carries an elevated risk of both infanticide and suicide when it goes untreated.

“She was reaching out for help, and she was not getting it,” Riddington said, as Clancy nodded from the defendant’s chair.

Since the trial, Clancy has filed suit against her physicians. The complaint alleges they failed to diagnose her properly and instead subjected her to what the filing describes as “a disorganized, uncoordinated course of polypharmacy that exacerbated her condition and precipitated a severe psychotic break.” All previously involved providers declined to comment while litigation is pending.

A Broader Lens on Psychiatric Pharmacology

Dr. Joseph Goldberg, a psychiatrist and psychopharmacologist with no connection to the Clancy case, framed the trial as a public reminder of how layered severe mental illness truly is — both in diagnosis and in treatment. His observation underscores a reality that extends well beyond one courtroom: psychiatric medication is the single most common intervention for mental health conditions in the United States. The Centers for Disease Control and Prevention estimates that nearly 20 percent of American adults currently take at least one psychiatric drug.

Yet the pharmacology involved is far from simple. Brain disorders do not yield to a single molecular target, and the latency period before a medication produces measurable benefit can stretch across weeks. Deciding when to switch agents, when to augment a regimen, and when to taper off a compound all require close, ongoing dialogue between patient and prescriber. There is no algorithm that replaces that conversation.

How Antidepressants Work — and Why They Take Time

Psychiatric medications cluster into roughly four or five major pharmacological families. The largest and most widely prescribed is the antidepressant class, which itself subdivides into several mechanisms.

Selective serotonin reuptake inhibitors — SSRIs such as Celexa, Prozac, and Zoloft — remain the first-line pharmacotherapy for a broad spectrum of depressive and anxiety disorders. They are regarded as highly effective, and their side-effect profile, while not trivial, tends to be mild: transient stomach upset, diminished libido, occasional headaches. Most of these effects attenuate over time.

The reason an SSRI typically requires four to eight weeks before a patient notices meaningful mood improvement lies in neurobiology. By blocking the rapid reuptake of serotonin into presynaptic cells, the drug keeps the neurotransmitter active in the synaptic cleft for a longer window. Over successive days, the brain compensates by desensitizing certain serotonin receptors. That downstream adaptation triggers the release of brain-derived neurotrophic factor, a protein that functions somewhat like fertilizer for neural tissue, encouraging the growth of new neurons and synaptic connections. Mood elevation, in other words, is a slow structural remodeling, not an instantaneous chemical switch.

An exception exists: when SSRIs are deployed for menstrual-cycle-related mood disturbances, their onset can be faster, owing to the hormonal milieu already acting on brain circuits.

Other antidepressant mechanisms target different neurotransmitter systems. Norepinephrine-dopamine reuptake inhibitors, exemplified by bupropion, block the reabsorption of norepinephrine and dopamine — chemicals implicated in stress response, reward processing, alertness, and sustained attention. Serotonin-norepinephrine reuptake inhibitors such as Cymbalta, Fetzima, and Effexor XR inhibit the reuptake of both serotonin and norepinephrine, thereby modulating the body’s fight-or-flight circuitry alongside mood regulation.

Anti-Anxiety Agents: Fast Relief, Narrow Window

Benzodiazepines — Ativan, Librium, Xanax, Valium — occupy a distinct niche. They act rapidly to blunt extreme worry, acute fear, social anxiety spikes, and panic attacks by enhancing the inhibitory action of gamma-aminobutyric acid across the nervous system. Their speed is precisely why clinicians prescribe them cautiously and for limited durations. Dependence develops readily, and when the nervous system’s excitatory activity drops too far, side effects can become dangerous, including respiratory depression and impaired coordination.

What the Clancy Case Reminds Patients and Providers

The trial does not settle a pharmacological question, but it sharpens a practical one: how do patients and clinicians navigate the trial-and-error inherent in psychiatric prescribing without losing trust, momentum, or, in the worst cases, lives? The answer lives in sustained communication, accurate diagnosis, and the willingness to adjust a regimen before a crisis crystallizes. For the nearly one in five Americans taking a psychiatric medication today, that conversation is not optional — it is the treatment.